<DOC>
	<DOCNO>NCT02517749</DOCNO>
	<brief_summary>This multicentre randomise control trial evaluate global health relate quality life outcome patient malignant pleural effusion . Patients randomise receive either chest drain talc pleurodesis indwell pleural catheter talc pleurodesis . Patients follow 3 month post intervention</brief_summary>
	<brief_title>Out Patient Talc Slurry Via Indwelling Pleural Catheter Malignant Pleural Effusion Vs Usual Inpatient Management</brief_title>
	<detailed_description />
	<mesh_term>Pleural Effusion</mesh_term>
	<mesh_term>Pleural Effusion , Malignant</mesh_term>
	<criteria>1 . Diagnosis malignant pleural effusion 2. WHO performance status 2 less unless performance status impair presence effusion likely significantly improve drainage 3 . Expected survival great 3 month 1 . Age le 18 year old 2 . Pregnant lactate 3 . Known allergy Talc Lignocaine 4 . Lack symptomatic relief effusion drainage 5 . At least twice weekly drainage undertaken 6 . Lymphoma small cell carcinoma except* : 1 . Failure chemotherapy 2 . Deemed palliative management 7 . Non malignant effusion 8 . Loculated pleural effusion 9 . Unable provide write informed consent trial participation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>